ESC 365 - Shifting clinical guidelines in type 2 diabetes and cardiovascular disease.

Open Access

Shifting clinical guidelines in type 2 diabetes and cardiovascular disease.

Session: The role of glucagon-like peptide-1 receptor agonists in cardiometabolic care

Topic: Pharmacotherapy

Speaker: Professor S. Verma (Toronto, CA)

Sponsored by Novo Nordisk A/S

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)

31 presentations

2 followers

4 more presentations in this session

Welcome and introduction.

Speaker: Professor M. Petrie (Glasgow, GB)

Exploring the link between type 2 diabetes and cardiovascular disease.

Speaker: Professor M. Petrie (Glasgow, GB)

Translating knowledge into clinical practice.

Speaker: Professor M. Kosiborod (Kansas City, US)

Panel discussion.

Speaker: Professor M. Petrie (Glasgow, GB) Professor S. Verma (Toronto, CA) Professor M. Kosiborod (Kansas City, US)

Access the full session

The role of glucagon-like peptide-1 receptor agonists in cardiometabolic care

Speakers: Professor S. Verma, Professor M. Petrie, Professor M. Petrie, Professor M. Kosiborod, Professor M. Petrie...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources